Viewing Study NCT05563766


Ignite Creation Date: 2025-12-24 @ 4:19 PM
Ignite Modification Date: 2025-12-27 @ 12:24 AM
Study NCT ID: NCT05563766
Status: RECRUITING
Last Update Posted: 2025-11-05
First Post: 2022-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
Sponsor: VA Office of Research and Development
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module